Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 20;168(2):69.
doi: 10.1007/s00705-022-05636-y.

Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia

Ghassen Kharroubi  1   2 , Ines Cherif  1   2 , Wissem Ghawar  1   2 , Nawel Dhaouadi  1 , Rihab Yazidi  1   2 , Sana Chaabane  1   2 , Mohamed Ali Snoussi  1   2 , Sadok Salem  1   2 , Wafa Ben Hammouda  2 , Sonia Ben Hammouda  2 , Adel Gharbi  1   2 , Nabil Bel Haj Hmida  1   2 , Samia Rourou  3 , Koussay Dellagi  2   4 , Mohamed-Ridha Barbouche  2 , Chaouki Benabdessalem  2 , Melika Ben Ahmed  2 , Jihène Bettaieb  5   6
Affiliations

Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia

Ghassen Kharroubi et al. Arch Virol. .

Abstract

The aim of this study was to measure the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among workers at the Institut Pasteur de Tunis (IPT), a public health laboratory involved in the management of the COVID-19 pandemic in Tunisia, and to identify risk factors for infection in this occupational setting. A cross-sectional survey was conducted on IPT workers not vaccinated against coronavirus disease 2019 (COVID-19). Participants completed a questionnaire that included a history of reverse transcription-polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection. Immunoglobulin G antibodies against the receptor-binding domain of the spike antigen (anti-S-RBD IgG) and the nucleocapsid protein (anti-N IgG) of the SARS-CoV-2 virus were detected by enzyme-linked immunoassay (ELISA). A multivariate analysis was used to identify factors significantly associated with SARS-CoV-2 infection. A total of 428 workers were enrolled in the study. The prevalence of anti-S-RBD and/or anti-N IgG antibodies was 32.9% [28.7-37.4]. The cumulative incidence of SARS-CoV-2 infection (positive serology and/or previous positive RT-PCR test) was 40.0% [35.5-44.9], while the proportion with asymptomatic infection was 32.9%. One-third of the participants with RT-PCR-confirmed infection tested seronegative more than 90 days postinfection. Participants aged over 40 and laborers were more susceptible to infection (adjusted OR [AOR] = 1.65 [1.08-2.51] and AOR = 2.67 [1.45-4.89], respectively), while tobacco smokers had a lower risk of infection (AOR = 0.54 [0.29-0.97]). The SARS-CoV-2 infection rate among IPT workers was not significantly different from that detected concurrently in the general population. Hence, the professional activities conducted in this public health laboratory did not generate additional risk to that incurred outside the institute in day-to-day activities.

Keywords: Health care workers; Risk factors; SARS-CoV-2 infection; Seroprevalence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. World Health Organization (2020) Prevention, identification and management of health worker infection in the context of COVID-19. https://www.who.int/publications/i/item/10665-336265. Accessed 15 Jan 2022
    1. Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2020;5:223–234. doi: 10.3138/jammi-2020-0030. - DOI - PMC - PubMed
    1. Perera RA, Mok CK, Tsang OT, et al. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. Euro Surveill. 2020;25:2000421. doi: 10.2807/1560-7917.ES.2020.25.16.2000421. - DOI - PMC - PubMed
    1. Oved K, Olmer L, Shemer-Avni Y, et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation. EClinicalMedicine. 2020;29:100651. doi: 10.1016/j.eclinm.2020.100651. - DOI - PMC - PubMed
    1. Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild Covid-19. N Engl J Med. 2020;383:1085–1087. doi: 10.1056/NEJMc2025179. - DOI - PMC - PubMed